Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
Disrupting maternal gut-immune axis perturbed immune networks in developing mouse brains, revealing potential mechanisms underlying neurodevelopmental disorders.